Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEP-aging: FMT for Aging and Frailty
NCT05598112Phase 1Recruiting
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Apr 2023
- Primary completion
- Dec 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in aging and frailty syndrome comparing FMT capsules with Placebo capsules (2 arms). Primary endpoint: Proportion of participants with reduced frailty score at 96 weeks. Started Apr 2023; status: recruiting.
02
Drugs
fecal microbiome transplant
03
Conditions
agingfrailty syndrome
Beyond the preview
Go deeper on NCT05598112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05598112.